She also writes biographies for Story Terrace. A share repurchase is a reduction in the number of a public company's shares outstanding. It's accomplished by buying a portion of its shares on the ...

Roughly a quarter of a million people work on the processing line in American poultry plants. As they process the chicken we eat, they face dangerous conditions and poverty-level wages on a daily ...

Despite a healthy performance in the fourth quarter of 2024-25 (Q4FY25), the stock of India’s largest listed pharma company, Sun Pharmaceutical Industries (Sun Pharma), was under pressure on ...

"Recommended a Final dividend of Re 0.10 per share, subject to approval of members at the ensuing Annual General Meeting," said the pharma company in its exchange filing. “Approval of material ...

Stocktwits - Oric Pharmaceuticals’ stock hit its highest levels in three months on Thursday after the company unveiled promising preliminary results from its Phase 1b trial of ORIC-944, an AR ...

Finally, Maxim Group boosted their price target on Medicus Pharma from $10.00 to $20.00 and gave the company a “buy” rating in a research note on Thursday, May 8th. One equities research ...

A leading pharmaceutical company witnessed an 8 percent surge in its stock price after unveiling ambitious plans to achieve 20 percent revenue growth, coupled with expectations of improved margins.

With such a big gap in its global pricing system, the company is likely to take a major hit if Trump's policy is actually implemented. Chinese drug makers reliant on foreign partners to sell their ...

CommScope Holding Company, Inc. (NASDAQ:COMM) is considering selling its broadband connectivity and cable division, CCS, according to sources familiar with the matter, as the network ...

The top pharma company is scheduled to announce its Q4 results today on Thursday, 22 May 2025. Expectations are high across several market segments. In India, Sun Pharma's business is forecast to ...

For any pharma company aiming to stay competitive, harnessing these technologies is no longer optional, it’s the key to delivering safer, more effective therapies at the speed patients expect. To ...